Amplia Therapeutics Limited
1 day chart
Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.
T&Cs apply
About ATX
Amplia Therapeutics Limited (ATX) is an Australian pharmaceutical company advancing a pipeline of Focal Adhesion Kinase (FAK) inhibitors for cancer and fibrosis. FAK is an increasingly important target in the field of cancer and Amplia has a particular development focus in fibrotic cancers such as pancreatic and ovarian cancer. FAK also plays a significant role in a number of chronic diseases, such as idiopathic pulmonary fibrosis (IPF).
Find out what a historical investment in Amplia Therapeutics Limited would be worth today using our ATX stock calculator.
Sector
Health Care
CEO
-
Industry
Biotechnology
Website
ampliatx.com
$21M
-2.28
-
$0.06
$0.05
$0.06
$0.18
$0.05
Ready to start your investing journey with Stake?
Open an accountAnnouncements
ATX FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ATX
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ATX
on Stake
Buy ATX from A$3 brokerage
Invest in 2,500+ Aussie stocks and ETFs
CHESS-sponsored ASX trades
